A Phase II Study to Investigate the Efficacy of shortterm Everolimus in Addition to post-transplant Cyclophosphamide as graft-versus-host-prophylaxis after Allogeneic Stem Cell Transplantation (Octet-ever)
- Publication date
- 1 January 2020
- Publisher
- 'Springer Science and Business Media LLC'
